Du kannst Dir doch von Caly die aktuellen Pressevroeffentlichungen per mail schicken lassen - das ist alles! PDF ging nicht, also als word Text:
Form 25
CALYPTE BIOMEDICAL CORP - HIV Filed: August 17, 2006 (period: )
Notification filed by National Securities Exchange to report the removal from listing and registration of matured, redeemed or retired securities
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 000-20985
Calypte Biomedical Corporation; American Stock Exchange (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
5 Centerpointe Drive, Suite 400 Lake Oswego, Oregon 97035 (971) 204-0282
Common stock, par value $0.03 per share (Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
|_| 17 CFR 240.12d2-2(a)(1)
|_| 17 CFR 240.12d2-2(a)(2)
|_| 17 CFR 240.12d2-2(a)(3)
|_| 17 CFR 240.12d2-2(a)(4)
|_| Pursuant to 17CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.
|X| Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
--------------------------------------------------
Pursuant to the requirements of the Securities Exchange Act of 1934, Calypte Biomedical Corporation certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
Calypte Biomedical Corporation
By: /s/ Theodore R. Gwin -------------------- Theodore R. Gwin Chief Financial Officer
Dated: August 17, 2006 |